Search

Theranostics, a remarkable combination of diagnostics and therapeutics, has given rise to tissue/organ-format theranostic scaffolds that integrate targeted therapy and real-time disease monitoring. The scaffold is a 3D structuring template for cell or tissue attachment and growth. These scaffolds offer unprecedented opportunities for personalized medicine and hold great potential for revolutionizing healthcare. Recent advancements in fabrication techniques have enabled the creation of highly intricate and precisely engineered scaffolds with controllable physical and chemical properties, enhancing their therapeutic potential for tissue engineering and regenerative medicine. This paper proposes a new categorization method for scaffolds in tissue engineering based on the relativity of scaffold design-independent parameters. Five types of scaffolds are defined at different levels, highlighting the importance of understanding and analyzing scaffold types. It possesses the ability to seamlessly integrate diagnostics and therapeutics within a single platform, enhancing the efficacy and precision of personalized medicine. Natural scaffolds derived from biomaterials and synthetic scaffolds fabricated by human intervention are discussed, with synthetic scaffolds offering advantages such as tunable mechanical properties and controlled drug delivery, while natural scaffolds provide inherent biocompatibility and bioactivity, making them ideal for promoting cellular responses. The use of synthetic scaffolds shows great promise in advancing regenerative medicine and improving patient outcomes. The transfer of new technologies and changes in society have accelerated the evolution of health monitoring into the era of personal health monitoring. Using emerging health data, cost-effective analytics, wireless sensor networks, mobile smartphones, and easy internet access, the combination of these technologies is expected to accelerate the transition to personal health monitoring outside of traditional healthcare settings. The main objective of this review article is to provide a comprehensive overview of the theranostic applications of scaffolds in current biomedical research, highlighting their dual role in therapy and diagnostics. The review aims to explore the latest advancements in scaffold design, fabrication, and functionalization, emphasizing how these innovations contribute to improved therapeutic efficacy, targeted drug delivery, and the real-time monitoring of disease progression across various medical fields., Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Patil et al.)

The purpose of nanotechnology-based drug delivery systems or novel drug delivery systems is to improve the effectiveness of therapy, and their promising properties have led to their increasing significance in the management of cancer. The researchers have primarily focused on designing novel nanocarriers, like nanoparticles (NPs), that can effectively deliver drugs to target cells and respond specifically to conditions particular to cancer. Whether passive or active targeting, these nanocarriers can deliver therapeutic cargoes to the tumor site to release the drug from the drug delivery systems. The purpose of this study is to provide recent scientific literature and key findings to researchers as well as the scientific community from the medical and pharmaceutical domains by reporting current advancements in the development of NPs for the treatment of different malignant solid tumors, such as colorectal, pancreatic, prostate, and cervical cancer., Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Chavan et al.)

In recent years, the design of pharmaceutical cocrystals has garnered significant attention. The process of cocrystallization offers a remarkable opportunity to develop drug products with enhanced properties such as improved stability, solubility, hygroscopicity, dissolution rate, and bioavailability. This detailed review delves into this evolving area, thereby exploring its relevance in pharmaceutical formulation by defining cocrystals and their practical applications and also by discussing methods for their preparation as well as characterization. It also contrasts traditional and innovative techniques for cocrystal formation. Historically, cocrystals have been synthesized using methods like solvent evaporation, grinding, and slurry techniques; however, each has its own set of limitations under specific conditions. The latest trends in cocrystal formation lean toward more advanced approaches such as spray-drying, hot melt extrusion, and supercritical fluid technology, as well as the cutting-edge technique of laser irradiation. The aim behind developing new methods is not just to address the limitations of traditional cocrystallization techniques but also to streamline the process by introducing simpler steps and enabling a continuous production workflow for cocrystal products. In general, this full-length review article offers a report on various techniques available for the creation of pharmaceutical cocrystals, along with the methods for their evaluation. Moreover, it includes reporting developments and diverse applications of cocrystals along with the commercially available cocrystals in the pharmaceutical as well as medical domains., Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Chavan et al.)

Nanoparticles play a vital role in modern agriculture to provide the nutrients required by plants. Herein, we report the preparation of calcium-doped zinc oxide nanoparticles (CZO NPs) via a simple and cost-effective co-precipitation method, with the aim of realizing increased fertilizer response. The synthesized nanoparticles were analyzed to study their physicochemical properties using various characterization techniques. The X-ray diffraction pattern showed a small shift in peak position towards higher values of 2θ and reduced crystal size after the zinc oxide (ZnO) matrix had been doped with Ca. Field-emission scanning electron microscopy images clearly revealed a grain-like surface morphology. The X-ray photoelectron spectroscopy study produced evidence of Zn 2+ substitution by Ca 2+ and enhanced Zn-O bond strengths in the CZO samples. Two major crops, maize (Zea mays L.) and wheat (Triticum aestivum L.) were selected to study the impact of the CZO NP-based nanofertilizer on plant growth. During the study, the effect of the CZO-based fertilizer on growth parameters such as seed germination, root and shoot length, plant height, root and stem width, number of leaves, and leaf size was studied based on comparisons with control plants. We observed significantly increased plant growth parameters after the application of the CZO NP-based fertilizers., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: S. A. Vanalakar reports financial support was provided by Shivaji University. Jaewoong Lee reports financial support was provided by Korea Ministry of Trade Industry and Energy. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)

Nanocarriers have attracted considerable interest due to their prospective applications in the delivery of anticancer medications and their distinct bioactivities. Biogenic nanostructures can be effective nanocarriers for delivering drugs as a consequence of sustainable and biodegradable biomass-derived nanostructures that perform specific functions. In this case, a vanadium oxide (V 2 O 5 ) and mesoporous carbon@V 2 O 5 (C@V) composite was developed as a possible drug delivery system, and its bioactivities, including antioxidant, antibacterial, and anticancer, were investigated. Doxorubicin (DOX), an anticancer drug, was introduced to the nanoparticles, and the loading and release investigation was conducted. Strong interfacial interactions between mesoporous carbon (MC) and V 2 O 5 nanostructures have been found to improve performance in drug loading and release studies and bioactivities. After incubation, the potent anticancer effectiveness was seen based on C@V nanocomposite. This sample was also utilized to research potential biomedical uses as an antioxidant, antibacterial, and anticancer. The most effective antioxidant, the C@V sample (61.2%), exhibited a higher antioxidant activity than the V-2 sample (44.61%). The C@V sample ultimately attained a high DOX loading efficacy of 88%, in comparison to a pure V 2 O 5 sample (V-2) loading efficacy of 80%. Due to the combination of mesoporous carbon and V 2 O 5 , which increases specific surface area and surface sites of action as well as the morphology, it proved that the mesoporous carbon@V 2 O 5 composite (C@V) sample demonstrated greater efficacy.

Rheumatoid arthritis (RA) is a chronic condition causing joint pain and inflammation that has now spurred the interest in nanotechnology-based drug delivery for more effective treatment, and in this regard, carbon nanotubes (CNTs) are being explored for their potential to deliver the drugs steadily to manage the RA. Many investigators have been investigating both single-walled carbon nanotubes (SWCNT) as well as multi-walled carbon nanotubes (MWCNT) for managing arthritis via targeted drug delivery. Moreover, functionalized CNTs show promise in delivering the drugs precisely and in a controlled manner, thereby minimizing toxicity. However, research on applications of CNTs as drug carriers for RA remains limited, thus necessitating further exploration to address the various challenges. In this present piece of writing, challenges in RA treatment and the advances in applications of CNTs for RA management are reported, consequently reflecting the CNTs as advanced drug delivery vehicles for arthritis treatment., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)

Scientists have investigated the possibility of employing nanomaterials as drug carriers. These nanomaterials can preserve their content and transport it to the target region in the body. In this investigation, we proposed a simple method for developing distinctive, bioderived nanostructures with mesoporous carbon nanoparticles impregnated with tungsten oxide (WO 3 ). Prior to characterizing and encapsulating WO 3 with bioderived mesoporous carbon, the anticancer drug doxorubicin (DOX) was added to the nanoparticles and examined loading and release study. The approaches for both nanoparticle production and characterization are discussed in detail. Colloidal qualities of the nanomaterial can be effectively preserved while also allowing transdermal transportation of nanoparticles into the body by forming them into green, reusable, and porous nanostructures. Although the theories of nanoparticles and bioderived carbon each have been studied separately, the combination presents a new route to applications connected to nanomedicine. Furthermore, this sample was used to study exotic biomedical applications, such as antioxidant, antimicrobial, and anticancer activities. The W-3 sample had lower antioxidant activity (44.01%) than the C@W sample (56.34%), which was the most potent. A high DOX entrapment effectiveness of 97% was eventually achieved by the C@W sample, compared to a pure WO 3 entrapment efficiency of 91%. It was observed that the Carbon/WO 3 composite (C@W) sample showed more efficacy because the mesoporous carbon composition with WO 3 increases the average surface area and surface-active locations.

The solar thermochemical CO 2 splitting (CDS) is scrutinized via a redox ZnO/Zn cycle. The second law efficiency analysis is carried out by acquiring the required thermodynamic data from HSC Chemistry software. The main focus of this study is to explore the influence of reduction temperature (T red ), molar flow rate of inert sweep gas (n˙ inert ), and energy required for the gas separation on the solar-to-fuel energy conversion efficiency (η solar-to-fuel ) of the ZnO/Zn cycle. All the calculations are conducted at a constant gas-to-gas heat recovery effectiveness (ε gg ) equal to 0.5. n˙ inert required is recorded to be too high (5050 mol/s) at T red equal to 1500 K and moderately low (15 mol/s) for T red equal to 2000 K. The amount of thermal energy required to heat the inert/O 2 gas mixture (from CDS temperature to separator-1 temperature) and inert sweep gas (from separator-1 temperature to reduction temperature) has a significant impact on the total thermal energy requirement of the cycle (Q˙ TC ). The rise in T red from 1500 K to 2000 K shows a considerable decline in Q˙ TC from 77417.5 kW to 1161.8 kW, respectively. Consequently, the highest η solar-to-fuel (17.0%) is recorded for T red equal to 2000 K., (Copyright © 2022 Elsevier Inc. All rights reserved.)

Current discoveries as well as research findings on various types of carbon nanostructures have inspired research into their utilization in a number of fields. These carbon nanostructures offer uses in pharmacy, medicine and different therapies. One such unique carbon nanostructure includes carbon nanotubes (CNTs), which are one-dimensional allotropes of carbon nanostructure that can have a length-to-diameter ratio greater than 1,000,000. After their discovery, CNTs have drawn extensive research attention due to their excellent material properties. Their physical, chemical and electronic properties are excellent and their composites provide great possibilities for enormous nanometer applications. The current study provides a systematic review based on prior literature review and data gathered from various sources. The various research studies from many research labs and organizations were systematically retrieved, collected, compiled and written. The entire collection and compilation of this review concluded the use of CNT approaches and their efficacy and safety for the treatment of various diseases such as brain tumors or cancer via nanotechnology-based drug delivery, phototherapy, gene therapy, antiviral therapy, antifungal therapy, antibacterial therapy and other biomedical applications. The current review covers diverse applications of CNTs in designing a range of targeted drug delivery systems and application for various therapies. It concludes with a discussion on how CNTs based medicines can expand in the future.

In the present study, we aimed to develop a novel pH-sensitive polymeric delivery system (GG- g -PMMA) for antidiabetic therapy via grafting ghatti gum (GG) with methyl methacrylate (MMA) chains. The free radical polymerization technique was adopted to graft ghatti gum with methyl methacrylate, using ceric ammonium nitrate (CAN) as a redox initiator. The impact on grafting parameters such as grafting percentage ( G %) and grafting efficiency (GE), of monomer and initiator concentrations was evaluated. The batch with higher grafting efficiency and percentage grafting was selected and characterized by elemental analysis (C, H and N), DSC, FT-IR spectroscopy, XRD, 1 H-NMR and SEM morphology study. In addition, the efficacy of GG- g -PMMA-based pellets loaded with the hypoglycemic agent, metformin hydrochloride, to sustain drug release was investigated. In vitro release studies demonstrated a pH-dependent sustained release of the drug from GG- g -PMMA pellets. In addition, acute oral toxicity studies and histopathological analysis suggested the safety and biocompatibility of the grafted gum. Most importantly, in vivo efficacy studies underscored the efficient hypoglycemic potential of the prepared formulation, which was comparable to that of a sustained release marketed formulation. These results suggest that the developed pH-sensitive polymeric delivery system (GG- g -PMMA) might represent a promising delivery vehicle for facilitated antidiabetic therapy., Competing Interests: The authors declare no conflict of interest., (This journal is © The Royal Society of Chemistry.)

The treatment of waste gas (WG) containing dichloromethane (DCM) using advanced oxidation processes (AOPs) [UV and UV-TiO 2 ], biological treatment (BT), and their combination (AOPs-BT) was tested. AOP tests were performed in an annular photo-reactor (APHR), while BT was conducted in a continuous stirred tank bioreactor (CSTBR). The effects of gas flow rate (Q gas ), inlet DCM concentration ([DCM] i ), residence time (τ), photocatalyst loading (PH-C L ) and % relative humidity (% RH) on the AOPs performance and the removal of DCM (%DCM r ) were studied and optimized. The UV process exhibited %DCM r ≤ 12.5 % for tests conducted at a [DCM] i ≤ 0.45 g/m 3 , Q gas of 0.12 m 3 /h and τ of 27.6 s, respectively, and < 4 % when the [DCM] i ≥ 4.2 g/m 3 . The UV-TiO 2 achieved a %DCM r ≥ 71 ± 1.5 % at Q gas of 0.06 m 3 /h, [DCM] i of 0.45 g/m 3 , τ of 55.2 s, PH-C L of 10 g/m 2 , and %RH of 50, respectively. The BT process removed ∼97.6 % of DCM with an elimination capacity (EC) of 234.0 g/m 3 ·h. Besides, the high %DCM r of ∼98.5 % in the UV-BT and 99.7 % in the UV-TiO 2 -BT processes confirms AOPs-BT as a promising technology for the treatment of recalcitrant compounds present in WG., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)

The present study evaluates the effect of an acidic treatment on the improvement of the percentage removal of toxic metal (%TM rem ) from wastewater by algae strains (Spirulina platensis (SP) and Chlorella vulgar (CV)) under different adsorbent dosages (0.2-2.5 g), a pH of (4-8) and contact time (5-100 min). The acidic treatment (Ac-T) altered the functional groups on the surface of algae promoting more electronegative groups and improved the %TM rem of Al, Ni and Cu. Treated SP removed up to 95.0 ± 0.3% (Std. Dev = 0.24), 87.0 ± 0.2% (Std. Dev = 0.34)%, and 63.0 ± 0.3% (Std. Dev = 0.14) of Al, Ni, and Cu at the optimum pH of 5.5, 6.0, and, 7.0 and an adsorbent dosage of = 2.5 ± 0.1 g/L (Std. Dev = 0.14) g/L, respectively. Lower %TM rem of 87.0% ± 0.2 (Std. Dev = 0.09), 79.1 ± 0.4% (Std. Dev = 0.08), and 80.0 ± 0.2% (Std. Dev = 0.04) were achieved with treated CV, respectively. The optimum operational conditions for maximum %TM rem were determined at (C algae  = 4.8 ± 0.2 g MNPs .L -1 , C t  = 88 ± 1, and pH = 6) using the response surface methodology (RSM). The adsorption of TMs on algae is endothermic, spontaneous, and follows Langmuir and second-order kinetics. Zeta potential measurements indicated that the adsorption mechanism between the toxic metal (TM) and algal strains is controlled by electrostatic interaction. As such, bio-sorption is a sustainable and efficient technology for the removal of TM from wastewater., Competing Interests: Declaration of competing interest There are no known conflicts of interest associated with this publication., (Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.)

Due to their rapid growth rates, high lipid productivity, and ability to synthesize value-added products, microalgae are considered as the potential biofuel feedstocks. However, among the several bottlenecks that are hindering the commercialization of microalgal biofuel synthesis, the issue of high water consumption is the least explored. This analysis, therefore, examines the factors that decide water use for the production of microalgae biofuel. Microalgae biodiesel water footprint varies from 3.5 to 3726 kg of water per kg of biodiesel. The study further investigates the cause for large variability in the estimation of the water footprint for microalgae fuel. Various strategies, including the reuse of harvested water, the use of high density cultivation that could be adopted for low water consumption in microalgal biofuel production are discussed. Specifically, the review identified a reciprocal relationship between biomass productivity and water footprint. On the basis of which the review emphasizes the significance of high density cultivation, which can be inexpensive and feasible relative to other water-saving techniques. With the setback of water scarcity due to the rapid industrialization in developing countries, the implementation of the cultivation system with a focus on minimizing the water consumption is inevitable for a successful large scale microalgal biofuel production., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier B.V. All rights reserved.)

Glioblastoma multiforme (GBM), a standout among the most dangerous class of central nervous system (CNS) cancer, is most common and is an aggressive malignant brain tumor in adults. In spite of developments in modality therapy, it remains mostly incurable. Consequently, the need for novel systems, strategies, or therapeutic approaches for enhancing the assortment of active agents meant for GBM becomes an important criterion. Currently, cancer research focuses mainly on improving the treatment of GBM via diverse novel drug delivery systems. The treatment options at diagnosis are multimodal and include radiation therapy. Moreover, significant advances in understanding the molecular pathology of GBM and associated cell signaling pathways have opened opportunities for new therapies. Innovative treatment such as immunotherapy also gives hope for enhanced survival. The objective of this work was to collect and report the recent research findings to manage GBM. The present review includes existing novel drug delivery systems and therapies intended for managing GBM. Reported novel drug delivery systems and diverse therapies seem to be precise, secure, and relatively effective, which could lead to a new track for the obliteration of GBM.

Large amounts of agricultural solid wastes (ASWs) and animal dung are produced annually causing serious environmental problem that requires proper treatment. The present study proposes a strategy for optimizing the anaerobic co-digestion of ASWs and cow dung (CD), identifies the key factors governing the co-digestion performance and evaluates the effect of NaHCO 3 alkalinity treatment on improving the economy and performance of anaerobic digestion (AD). The results revealed that the highest cumulative methane production (CMP) of 297.99 NL/kgVS can be generated by co-digestion of ASWs and CD at a ratio of 60:40. Further improvement was achieved via alkalinity treatment with 1.0 g of NaHCO 3 /gVS leading to decrease in lignin, cellulose, and hemicellulose contents of feedstock by 3.5%, 10.5% and 15.9%, respectively, converting them to soluble fractions and improving the CMP by 11.2-29.7% based on substrate quality. The improved CMP in the chemically treated substrates reflects a 19% increase in the generated revenue. The kinetics of the AD process was successfully fitted to modified Gompertz model with very low standard deviation residuals (SDR) ≤ 5.21 and R 2  ≥ 0.979. Results confirm that the proposed strategy is an effective method for producing biogas from co-digestion of ASWs and CD., (Copyright © 2020 Elsevier Ltd. All rights reserved.)

The objective of the present study was to develop a pH-sensitive drug delivery system by using polymethylmethacrylate-grafted gellan gum (PMMA-g-GG). PMMA-g-GG was synthesized by free radical polymerization reaction by using redox initiator ceric ammonium nitrate (CAN), and a series of graft copolymers were prepared with varying concentrations of methylmethacrylate (MMA) and CAN. Grafting parameters such as the percentage and efficiency of grafting were calculated, and the effect of monomer as well as initiator concentration was studied on the grafting yield. Optimization was done by one optimal response surface methodology. The batch with a better percentage grafting and grafting efficiency was selected and characterized by elemental analysis (CHN), FT-IR, DSC, PXRD, 1 H-NMR, and SEM. Furthermore, acute oral toxicity study and histopathological analysis suggested non-toxic and biocompatible nature of the grafted gum. Metformin hydrochloride pellets were prepared using PMMA-g-GG, characterized in detail, and assessed for biocompatibility and efficacy. PMMA-g-GG-based formulation (M4) exhibited a pH-sensitive as well as sustained release of the drug over the period of 12 h and the release profile followed Peppas model. In vivo efficacy studies indicated a promising antidiabetic potential of the prepared formulation. Thus, PMMA-g-GG-based formulations can be implicated as novel drug delivery systems for facilitated antidiabetic therapy in the near future. Graphical abstract.

This review examines in detail the production and characteristics of biochar resulting from hydrothermal liquefaction. Specifically, the impact of feedstocks and different process parameters on the properties and yield of biochar by hydrothermal liquefaction has been thoroughly studied. Hydrothermal liquefaction derived biochars, relative to biochars from high-temperature thermochemical processes retain critical functional groups during carbonization and are therefore promising for a wide range of applications. Most of the review's efforts are to study possible hydrothermal liquefaction biochar applications in various fields, including fuel, metal and dye adsorption, pollutant reduction, animal feed, and biogas catalyst. The feasibility of biochar through the hydrothermal liquefaction process has been analysed via life-cycle assessment and energy evaluation. The article concludes with a brief discussion on possible issues and strategies for the sustainable development of hydrothermal liquefaction-based biochar., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)

The present study aimed to enhance the biomethanation potential of mixed microalgae via cost effective surfactant coupled ultrasonic homogenization (SCUH). Mixed microalgae biomass was harvested using a coagulant (Alum) from a raceway pond. The harvested algal biomass was subjected to ultrasonic homogenization (UH) by varying the power from 100 to 180 W. A maximal soluble organic release of 2131 mg/L was achieved at an ultrasonic input energy (UIE) of 25200 kJ/kg TS. In order to enhance soluble organic release and to reduce energy spent, the optimized condition of ultrasonic pretreatment was coupled with varying sodium dodecyl sulphate (SDS) dosage. A higher solubilization of 30.5% was achieved at a UIE of 4200 kJ/kg SS with surfactant dosage of 0.02 g SDS/g SS for SCUH. SCUH showed higher methane production of 358 mL/g COD when compared to UH (185.9 mL/g COD), SCUH was economically feasible than UH., (Copyright © 2020 Elsevier Ltd. All rights reserved.)

The aim of this review is to summarize the modern developments and enhancement strategies reported for improving the biorefinery route of industrial wastewater to biohydrogen. Recent developments towards biohydrogen production chiefly involves culture enrichment, pretreatment of biocatalysts, co culture fermentation, metabolic and genetic engineering, ecobiotechnological approaches and the coupling process of biohydrogen. In addition, an overview of dark fermentation, pathways involved, microbes involved in biohydrogen production, industrial wastewater as substrate have been focused. The utilization of organic residuals of dark fermentation for subsequent value added products are highlighted. More apparently, the two stage coupling process and its possibilities towards biorefinery has been reviewed comprehensively. Moreover, comparative energy and economic aspects of biohydrogen production from industrial wastewater and its prospects towards pilot scale applications are also spotlighted. Though all the enhancement strategies have both benefits and disadvantages, coupling process is considered as the most successful biorefinery route for biohydrogen production., (Copyright © 2019 Elsevier Ltd. All rights reserved.)

The production of bio/microbial-based polymers, polyhydroxyalkanoates (PHAs) from volatile fatty acids (VFAs) of dark fermentative effluents in the bio-H 2 reactor is being paid attention, owing to their commercial demand, applications and as carbon as well as energy storage source. Since, they are the cheap precursors for such valuable renewable biopolymers which all possess the properties; those are analogous to the petro-derived plastics. Several studies were stated, related to the consumption of both individual and mixed VFAs for the potential PHAs production. Their biodegradability nature makes them extremely desirable alternative to fossil-derived synthetic polymers. In this regard, this review summarizes the use of bio-based PHAs production via both microbial and biochemical pathways using dark fermentative bio-H 2 production from waste streams as feedstock. Furthermore, this review deals the characteristics, synthesis and production of the bio-based PHAs along with their co-polymers and applications to give an outlook on future research., (Copyright © 2019 Elsevier Ltd. All rights reserved.)

The increase in atmospheric CO 2 concentration and the release of nutrients from wastewater treatment plants (WWTPs) are environmental issues linked to several impacts on ecosystems. Numerous technologies have been employed to resolves these issues, nonetheless, the cost and sustainability are still a concern. Recently, the use of microalgae appears as a cost-effective and sustainable solution because they can effectively uptake CO 2 and nutrients resulting in biomass production that can be processed into valuable products. In this study single (Spirulina platensis (SP.PL) and mixed indigenous microalgae (MIMA) strains were employed, over a 20-month period, for simultaneous removal of CO 2 from flue gases and nutrient from wastewater under ambient conditions of solar irradiation and temperature. The study was performed at a pilot scale photo-bioreactor and the effect of feed CO 2 gas concentration in the range (2.5-20%) on microalgae growth and biomass production, carbon dioxide bio-fixation rate, and the removal of nutrients and organic matters from wastewater was assessed. The MIMA culture performed significantly better than the monoculture, especially with respect to growth and CO 2 bio-fixation, during the mild season; against this, the performance was comparable during the hot season. Optimum performance was observed at 10% CO 2 feed gas concentration, though MIMA was more temperature and CO 2 concentration sensitive. MIMA also provided greater removal of COD and nutrients (~83% and >99%) than SP.PL under all conditions studied. The high biomass productivities and carbon bio-fixation rates (0.796-0.950 g dw ·L -1 ·d -1 and 0.542-1.075 g C ·L -1 ·d -1 contribute to the economic sustainability of microalgae as CO 2 removal process. Consideration of operational energy revealed that there is a significant energy benefit from cooling to sustain the highest productivities on the basis of operating energy alone, particularly if the indigenous culture is used., (Copyright © 2019 Elsevier B.V. All rights reserved.)

Pancreatic cancer (PC) is one of the most fatal solid tumors, resulting in more than 250,000 deaths per year globally. It is the eighth leading cause of death from cancer in men and women throughout the world and is now third leading cause of cancer-related deaths in the United States. In addition, the worldwide occurrence of PC ranges from 1 to 10 cases per 100,000 people, indicating a higher incidence in developed countries. Most patients with locally advanced or metastatic disease are not candidates for curative resection due to enormously poor prognosis. Substantial efforts have been taken during the past decade to distinguish better treatments in the absence of efficient screening methods. Regardless of wide-ranging efforts, various systems and therapies have shown insufficient efficacy for PC patients. Therefore, the development of novel drug delivery systems, strategies, and diverse therapeutic approaches to improve the range of active molecules for the treatment of PC is critical. Currently, cancer research focuses on improving the treatment of PC via diverse novel drug delivery systems of chemotherapeutic agents. These novel drug delivery systems consist of nanoparticles and liposomes. Strategies or therapeutic approaches intended for PC include radiation therapy, ablation therapy, and gene therapy. These systems and approaches can carry the drug molecules to targeted cancer cells to enhance the effectiveness of tumor penetration. The present review encloses existing novel drug carrier systems and approaches for PC management.

Nanotechnology and nanomedicines are emerging research meadows; which chiefly focuses on creating and manipulating materials at a nanometer level for the betterment in imaging, diagnosis and treatment of a range of diseases together with cancer. Cyclodextrin-based nanosponges, anticipated as a new-fangled nanosized delivery system, are ground-breaking hyper-crosslinked cyclodextrin polymers nanostructured within a three-dimensional network. Nanosponges based systems hold the potential of elevating the solubility, absorption, penetration, bioavailability, in vivo stability, targeted as well as sustained delivery, and therapeutic efficiency of numerous anticancer agents. The extension of nanosponges based drug delivery systems is an exhilarating and demanding research pasture, predominantly to overcome aforementioned problems allied to existing anticancer formulations and for the further progressions in cancer therapies. Nanosponges in cancer therapy, particularly cyclodextrin based nanosponges are brought up in this review. By quoting diverse attempts made in pertinent direction, efforts have been made to exemplify the characteristics, suitability and versatility of cyclodextrin based nanosponges for their promising applications in cancer treatment.

Background: Parasitic infection such as leishmaniasis, a neglected tropical disease, presents a significant global burden which is responsible for high mortality rate especially in less developed countries. Its intracellular nature and disseminated locations of parasite, limited number of chemotherapeutic agents, increasing incidences of resistance to first line drugs and toxicities, pose a great challenge to formulation scientists that have necessitated effective management of leishmanial infection by modulating the delivery of existing drugs. Over the past decade, research on development of alternative treatments such as nanotechnology-based drug delivery systems (nanoparticles, nanosuspensions, liposomes etc.), use of natural products as well as development of antileishmanial vaccine has been extensively investigated., Objective: The present review focuses on different facets of therapeutic strategies, existing miscellaneous drug delivery systems and approaches intended for management, as well as treatment of the infection, with an objective to summarize the current trends and strategies adopted for antileishmanial therapy in a systematic manner. Moreover, the article encloses an eclectic collection of patents allied to new-fangled chemotherapeutics for antileishmanial therapy., Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse approaches are seem to be precise, secure and relatively effective; and in an outcome, could lead to the new track for management of leishmaniasis., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)

Background: Prostate cancer (PC) is a prostate gland cells carcinoma, the foremost reason of cancer deaths in men in developed countries, representing most common malignancy in adult males. The key obstacle to achieve practicable therapeutic effect of active drugs and capable hopeful agents including proteins and peptides, and nucleic acid for prostate cancer is the scarcity of targeted drug delivery to cells of prostate cancer. As a result, need for novel systems, strategies or therapeutic approaches to enhance the assortment of active agents meant for prostate cancer becomes an important criterion. Currently cancer research focuses on improving treatment of prostate cancer using various novel drug delivery systems of chemotherapeutic agents. These novel drug delivery systems comprise nanoparticles and liposomes. Also, strategies or therapeutic approaches intended for the prostate cancer include radiation therapy for localized prostate cancer, hormonal therapy for suppressing tumor growth, and gene-and-immunologic therapy. These systems and approaches can deliver the drugs to their selected or targeted cancer cells for the drug release in cancer atmosphere of prostate thereby enhancing the effectiveness of tumor penetration., Objective: The objective was to collect and report the recent research findings to manage the PC. Present review encloses existing diverse novel drug delivery systems and approaches intended for the management of PC., Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse therapies are seem to be precise, secure and relatively effective; and in consequence could lead to a new track for obliteration of prostate cancer., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)

Objective: The rationale behind present research vocation was to develop and investigate a novel microsponge based gel as a topical carrier for the prolonged release and cutaneous drug deposition of fluconazole (FLZ); destined for facilitated fungal therapy., Materials and Methods: Microsponges were prepared using quasi-emulsion solvent diffusion method using Eudragit S-100. In the direction of optimization, the effect of formulation variables (drug-polymer ratio and amount of emulsifier) and diverse factors affecting physical characteristics of microsponge were investigated as well. Fabricated microsponges were characterized by differential scanning calorimetry, Fourier transform-infrared, scanning electron microscopy (SEM), particle size analysis, and also evaluated for drug content, encapsulation efficiency, in vitro drug release and in vitro antifungal activity., Results: Compatibility studies results reflected no sign of any chemical interaction between the drug and polymers used. Whereas, varied drug-polymer ratios and emulsifier concentration indicated significant effect on production yield, drug content, encapsulation efficiency, particle size and drug release. Spherical microsponges with a porous surface and 29.327 ± 0.31 μm mean particle size were evident from SEM micrographs. In vitro release outcomes, from microsponge loaded gels depicted that F1 formulation was more efficient to give extended drug release of 85.38% at the end of 8 h, while conventional formulation by releasing 83.17% of drug got exhausted incredibly earlier at the end of 4 h merely. Moreover, microsponge gels demonstrated substantial spreadability and extrudability along with promising antifungal activity., Conclusions: Fabricated microsponges would be impending pharmaceutical topical carriers of FLZ and a leading alternative to conventional therapy for efficient, safe and facilitated eradication of fungal infections.

Cervical cancer is uterine cervix carcinoma, the second deadly cancer and has a high incidence and mortality rate. In the developing world conventional treatment strategies such as surgical intervention and chemoradiotherapy are less widely available. Currently cancer research focuses on improving treatment of cervical cancer using various therapies such as gene therapy, recombinant protein therapy, photodynamic therapy, photothermal therapy and delivery of chemotherapeutic agents using nanoparticles, hydrogel and liposomal based delivery systems and also localized delivery systems which exist in a variety of forms such as intravaginal rings, intravaginal patches, intravaginal films, etc. in order to improve the drug delivery in a controlled manner to the diseased site thereby reducing systemic side effects. The present review encloses existing diverse delivery systems and approaches intended for treatment of cervical cancer.

The motive behind present work was to formulate and evaluate gel containing microsponges of diclofenac diethylamine to provide prolonged release for proficient arthritis therapy. Quasi-emulsion solvent diffusion method was implied using Eudragit RS-100 and microsponges with varied drug-polymer ratios were prepared. For the sake of optimization, diverse factors affecting microparticles physical properties were too investigated. Microsponges were characterized by SEM, DSC, FT-IR, XRPD and particle size analysis, and evaluated for morphology, drug loading, in vitro drug release and ex vivo diffusion as well. There were no chemical interactions between drug and polymers used as revealed by compatibility studies outcomes. The drug polymer ratio reflected notable effect on drug content, encapsulation efficiency and particle size. SEM results revealed spherical microsponges with porous surface, and had 7.21 μm mean particle size. The microsponges were then incorporated in gel; which exhibited viscous modulus along with pseudoplastic behavior. In vitro drug release results depicted that microsponges with 1:2 drug-polymer ratio were more efficient to give extended drug release of 75.88% at the end of 8 h; while conventional formulation get exhausted incredibly earlier by releasing 81.11% drug at the end of 4 h only. Thus the formulated microsponge-based gel of diclofenac diethylamine would be a promising alternative to conventional therapy for safer and efficient treatment of arthritis and musculoskeletal disorders.

The rationale behind present work was to formulate a novel cream containing microsponges of miconazole nitrate to provide prolonged release. By means of quasi-emulsion solvent diffusion method using Eudragit RS-100 with different drug-polymer ratios microsponges were prepared. In the direction of optimizing microsponge formulation, diverse factors that affect microparticles physical properties were also investigated. Microsponges were characterized by SEM, DSC, FT-IR and particle size analysis, and also evaluated for morphology, drug loading and in vitro drug release. The drug polymer ratio reflected notable effect on drug content, encapsulation efficiency and particle size. It has been found that there was no chemical interaction between drug and polymers used as revealed by FT-IR and DSC spectra. SEM micrographs exposed that microsponges were spherical, with porous surface and have had 26.23 μm mean particle size. The microsponges were then incorporated in cream; which showed viscous modulus along with pseudoplastic behavior. In vitro drug release results depicted that microsponge with drug-polymer ratio of 1:2 was more efficient to give extended drug release of 78.28% at the end of 8 h; while conventional formulations get exhausted incredibly earlier by releasing 83.09% drug at the end of 4 h only. Thus the formulated cream containing microsponges of miconazole nitrate would be a promising alternative as compared to conventional therapy for secure and efficient treatment of acne and other topical infections.